Navigation Links
CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis
Date:1/7/2008

ROSEVILLE, Calif., Jan. 7 /PRNewswire/ -- CoolTouch Inc., a pioneering manufacturer of medical lasers, announced today that the CoolLipo(TM) 1320 nm laser system received an additional 510(K) clearance from the U.S. Food and Drug Administration for laser lipolysis or melting fat. The CoolLipo 1320 laser is designed to ablate fat in areas such as the neck, chin and arms and improves the outcome of conventional liposuction in larger areas such as the abdomen and thighs. In addition, the unique 1320 nm wavelength tightens the skin from the inside out by directly targeting collagen and connective tissue. The CoolLipo procedure is performed in a physician's office under local anesthesia. Patient benefits include minimal, if any bruising, and less recovery time and cost than a face or neck lift.

"Patients find the procedure fits within their time schedule and their budget," states David R. Hennings, CoolTouch CEO. "This is an ideal procedure for those who aren't ready for a full face or neck lift, or have small fatty areas that don't respond to diet and exercise."

Douglas Key, MD, FACS from Key Laser Institute in Portland, Oregon has evaluated the safety and efficacy of laser lipolysis on the underchin & jowl of thirty patients. He found the 1320 wavelength in conjunction with conventional aspiration was twice as effective as aspiration alone.

"By choosing light that is more highly absorbed, we are finding more optimum results in terms of degree of skin tightening and greater comfort and recovery times for our patients," states Dr. Key.

Robert Weiss, MD, FACPh, Associate Clinical Professor of Dermatology at John Hopkins University School of Medicine, finds the 1320 wavelength provides an excellent skin tightening and fat contouring ability not seen with traditional liposuction alone.

"CoolLipo technology provides smoother results than with traditional lipoaspiration alone and makes these procedures significantly easier for both the patient and physician," states Dr. Weiss. "I have seen more of a skin tightening effect both when used adjunctively as well as principally."

A recently issued patent (#7,217,265) has been assigned exclusively to CoolTouch by inventors Dr. Mitchel P. Goldman, MD FACS from La Jolla SPA MD & Associate Clinical Professor of Dermatology/Medicine, University of California, San Diego in California and David Hennings, CoolTouch CEO. This patent covers several of the key features of the CoolLipo procedure, including subdermal skin tightening.

About CoolTouch

CoolTouch Inc. located in Roseville, California designs, manufactures and markets light-based aesthetic and medical products. The CoolTouch Nd:YAG product line includes: The CoolTouch CT3PLUS(TM) 1320 nm with CoolBreeze(TM) mode for painless acne and wrinkle treatment, the CoolTouch VARIA(TM) 1064 nm for hair removal, vascular conditions and skin tightening and the CoolTouch CTEV(TM) 1320 nm endovenous laser for treatment of varicose veins.

For more information please visit http://www.cooltouch.com


'/>"/>
SOURCE CoolTouch Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. A Whole New Sandwich Debuts in the Freezer Aisle: LEAN POCKETS(R) Brand Introduces Latest Whole Grain Varieties
2. GetWellNetwork Introduces GetConnected2008, Healthcares First Interactive Patient Care Conference
3. SGI Introduces the SGI BioCluster Life Sciences Workflow Solution
4. Radiology Support Devices Introduces New Breathing Phantom System
5. Ortho Organizers(R) Introduces Product Line Extension - Rectangular Super Elastic Nitanium(R) Black Ti(TM) Archwire
6. New Health Corp. Introduces Heart Savior(TM), the Ultimate Natural Heart Health Product
7. AACR introduces Cancer Prevention Research
8. Siemens Introduces Its New Generation of Artis Interventional Imaging Systems
9. Radlink Introduces New Family of Digital Imaging Products
10. Bioponic Phytoceuticals Introduces All Natural Baby Product Suite Gentle Mother
11. BioHorizons Introduces Its New Tapered Internal Implants Featuring Laser-Lok(R) Microgrooves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... (MRE), is pleased to be invited to the Siemens Healthineers annual customer education ... The event will take place from March 27 - 31, 2017 at ...
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have ... World Travel Trends Report). As travelers visit both urban destinations, they are faced ... prolonged sun exposure. In response, the outdoor industry has blurred the lines between ...
(Date:3/28/2017)... , ... March 28, 2017 ... ... non-profit medical society dedicated to advancing the science and clinical practice of ... its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in ... Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most ... kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)... 28, 2017  "US Cancer Generics Market Outlook ... indicators and trend analysis related to the emergence ... pharmaceutical market in US. The report analyzes various ... on cancer generics drugs in recent years. The ... billions of dollars for various stake holders involved ...
(Date:3/28/2017)... Therapeutics, Inc. (Nasdaq: OREX ) today announced ... year ended December 31, 2016. "Last ... beginning with the re-acquisition of the rights to Contrave® ... at Orexigen demonstrated remarkable focus, executing on a myriad ... Company while rewarding us full control of our FDA ...
Breaking Medicine Technology: